FGF2 and neoplasm: Tumor cells are known to activate angiogenesis by changing the balance of angiogenic inducers such as VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor), and by countervailing inhibitors such as thrombospondin-1 [29].